Literature DB >> 8812502

Mybl2 (Bmyb) maps to mouse chromosome 2 and human chromosome 20q 13.1.

K Noben-Trauth1, N G Copeland, D J Gilbert, N A Jenkins, G Sonoda, J R Testa, K H Klempnauer.   

Abstract

Mybl2 encodes a transcription factor that is thought to play an important role in cell cycle progression. Here we report the chromosomal localization of Mybl2 in mouse and human. Using mouse Mybl2 cDNA clones as probes, we assigned Mybl2 in an interspecific backcross panel to distal Chromosome 2. Using human cDNA probes in combination with FISH analysis, we localized MYBL2 to chromosome 20q13.1, a region that is commonly deleted in myeloid disorders. Both chromosomal regions are highly homologous, and the map positions, therefore, confirm each other. However, our findings are in contrast to a previous report by Barletta et al. (Cancer Res. 51:3821-3824, 1991) that placed the MYBL2 gene on human chromosome Xq13.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8812502     DOI: 10.1006/geno.1996.0408

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  3 in total

Review 1.  DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies.

Authors:  S Knuutila; A M Björkqvist; K Autio; M Tarkkanen; M Wolf; O Monni; J Szymanska; M L Larramendy; J Tapper; H Pere; W El-Rifai; S Hemmer; V M Wasenius; V Vidgren; Y Zhu
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

2.  Novel genomic imbalances in B-cell splenic marginal zone lymphomas revealed by comparative genomic hybridization and cytogenetics.

Authors:  J M Hernández; J L García; N C Gutiérrez; M Mollejo; J A Martínez-Climent; T Flores; M B González; M A Piris; J F San Miguel
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

3.  DNA sequence copy number aberrations associated with histological subtypes and DNA ploidy in gastric carcinoma.

Authors:  G Kong; A Oga; C K Park; S Kawauchi; T Furuya; K Sasaki
Journal:  Jpn J Cancer Res       Date:  2001-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.